Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients (Q35955325)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients |
scientific article |
Statements
1 reference
Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients (English)
1 reference
Isabel Stückrath
1 reference
Brigitte Rack
1 reference
Wolfgang Janni
1 reference
Bernadette Jäger
1 reference
Klaus Pantel
1 reference
Heidi Schwarzenbach
1 reference
1 May 2015
1 reference
1 reference
13387-13401
1 reference
1 reference
Identifiers
1 reference
1 reference